<!DOCTYPE html>
<html>
<head>
    <title>PressReader - The Straits Times: 2020-10-30 - Sev&#xAD;eral vac&#xAD;cines be&#xAD;ing tested in In&#xAD;done&#xAD;sia</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20201030/281809991400392" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>Sev&#xAD;eral vac&#xAD;cines be&#xAD;ing tested in In&#xAD;done&#xAD;sia</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20201030/textview" title="The Straits Times - 2020-10-30"><time>2020-10-30</time></a>
        - <span>THE BIG STORY</span>
        - <span role="byline"></span>
    </section>

    <p>JAKARTA • On Aug 11, pri­vate Chi­nese phar­ma­ceu­ti­cal firm Si­no­vac Biotech, and Bio Farma, an In­done­sian state-owned pharma com­pany, teamed up and launched phase three of a clin­i­cal trial for a Covid-19 can­di­date vac­cine in In­done­sia.</p>
    <p>Some 1,620 healthy In­done­sian vol­un­teers, aged 18 to 59, are in­volved in the six-month trial, whose out­come will de­ter­mine whether the vac­cine re­ceives reg­u­la­tory ap­proval.</p>
    <p>Ear­lier phase one and phase two tri­als were con­ducted on a smaller scale in China. They tested for vac­cine safety and im­muno­genic­ity – the abil­ity to trig­ger an im­mune re­sponse.</p>
    <p>Si­no­vac’s vac­cine is ex­pected to be the first on the In­done­sian mar­ket.</p>
    <p>The com­pany has said it is com­mit­ted to sup­ply­ing 1.5 mil­lion doses next month.</p>
    <p>Dr Neni Nu­rainy, Bio Farma’s re­search and devel­op­ment project se­nior in­te­gra­tion man­ager, told The Straits Times that the Si­no­vac vac­cine uses in­ac­ti­vated virus cells to stim­u­late im­mune re­sponse. In­ac­ti­vated means the virus has been killed, she said.</p>
    <p>“This method is a ma­ture and proven tech­nol­ogy that has been used to pro­duce vac­cines against in­fluenza and po­lio,” she added.</p>
    <p>Be­sides Si­no­vac, Kalbe Farma – In­done­sia’s big­gest phar­ma­ceu­ti­cal com­pany – has part­nered South Korean biotech firm Genex­ine to be­gin a phase two clin­i­cal trial for a Covid-19 vac­cine next month.</p>
    <p>In­done­sia is also plan­ning to pro­duce its own vac­cine, with­out the in­volve­ment of for­eign part­ners. It is known as Merah Pu­tih, or red and white, af­ter the colours of its na­tional flag.</p>
    <p>The vac­cine can­di­date is be­ing de­vel­oped by a na­tional con­sor­tium un­der the Re­search and Tech­nol­ogy Min­istry, led by the Ei­jk­man In­sti­tute for Molec­u­lar Bi­ol­ogy.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
